PRAXBIND®
Overview
PRAXBIND® is a specific reversal agent for dabigatran. PRAXBIND® is indicated in adult patients treated with PRADAXA® when rapid reversal of the anticoagulant effects of dabigatran is required.
Product overview
PRAXBIND® is a specific reversal agent for PRADAXA®.
Product Key Facts
![product_key2](/tw/sites/default/files/2023-02/product_key2_0.png)
Indication
PRAXBIND® is a specific reversal agent for dabigatran and is indicated in adult patients treated with PRADAXA® when rapid reversal of the anticoagulant effects of dabigatran is required:
- For emergency surgery/urgent procedures
- In life-threatening or uncontrolled bleeding
![product_key3](/tw/sites/default/files/2023-02/product_key3_0.png)
Active ingredients
Idarucizumab
![product_key4](/tw/sites/default/files/2023-02/product_key4.png)
Legal category
Prescription only medicine
![product_Key7](/tw/sites/default/files/2023-02/product_Key7_0.png)
Administration form
Intravenous bolus or infusion
![product_key6](/tw/sites/default/files/2023-02/product_key6_0.png)
Dosage form
Solution for injection/infusion
![product_key1](/tw/sites/default/files/2023-02/product_key1_0.png)
Pack sizes
50 mL solution in a glass vial (type I glass), with a butyl rubber stopper, an aluminum cap and a label with integrated hanger.
Pack size of 2 vials.
![product_key5](/tw/sites/default/files/2023-02/product_key5.png)
Storage
Store in a refrigerator (2 °C-8 °C).
Do not freeze.
Store in the original package in order to protect from light.
Prior to use, the unopened vial may be kept at room temperature (25 °C) for up to 48 hours, if stored in the original package in order to protect from light, or up to 6 hours when exposed to light.
Reference:
-
PRAXBIND® approved package insert. Updated in May 2019 and approved in November 2019.